Mark A Boyd Selected Research

Mark A Boyd Research Topics

6	Infections 09/2023 - 01/2014
3	Coinfection 01/2014 - 10/2003
2	Necrosis 11/2021 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2017 - 01/2013
2	Tuberculosis (Tuberculoses) 01/2017 - 04/2006
2	Disease Progression 01/2017 - 05/2004
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2014 - 01/2010
2	Injection Site Reaction 01/2010 - 01/2008
1	Atrial Fibrillation 09/2021
1	Vomiting 01/2021
1	Chlamydia Infections 01/2021
1	Sepsis (Septicemia) 01/2021
1	Nausea 01/2021
1	Diarrhea 01/2021
1	Inflammation (Inflammations) 01/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2020
1	Tobacco Use Disorder (Nicotine Dependence) 12/2018
1	Chronic Renal Insufficiency 11/2017
1	Cryptococcal Meningitis 01/2017
1	Malnutrition (Nutritional Deficiencies) 05/2016
1	Substance-Related Disorders (Drug Abuse) 05/2016
1	Genetic Risk Score 07/2015
1	Viremia 05/2014
1	HIV Infections (HIV Infection) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013
1	Lipodystrophy 01/2013
1	Pyuria 06/2006
1	Nephrolithiasis 06/2006
1	Hepatitis 05/2004

4	Ritonavir (Norvir)FDA Link 01/2015 - 04/2006
4	Lopinavir FDA Link 01/2015 - 01/2013
3	NucleosidesIBA 01/2015 - 01/2013
3	Raltegravir Potassium FDA Link 01/2015 - 01/2013
3	Indinavir (Crixivan)FDA Link 01/2014 - 04/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2023 - 01/2021
2	Lipopolysaccharide ReceptorsIBA 11/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2021
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2021 - 01/2020
2	Reverse Transcriptase InhibitorsIBA 01/2018 - 01/2013
2	Tenofovir (Viread)FDA Link 05/2016 - 01/2014
2	Atazanavir Sulfate (Reyataz)FDA Link 07/2015 - 01/2014
2	Enfuvirtide (Fuzeon)FDA Link 01/2010 - 01/2008
2	RNA (Ribonucleic Acid)IBA 06/2006 - 05/2004
1	C-Reactive ProteinIBA 11/2021
1	InterleukinsIBA 11/2021
1	fibrin fragment D (D-dimer)IBA 11/2021
1	NeopterinIBA 11/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	Anti-HIV Agents (AIDS Drugs)IBA 11/2017
1	lipoarabinomannan (LAM)IBA 01/2017
1	Nevirapine (Viramune)FDA Link 07/2015
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 07/2015
1	Cytochrome P-450 CYP3AIBA 07/2015
1	Antiviral Agents (Antivirals)IBA 01/2014
1	NucleotidesIBA 01/2013
1	LipidsIBA 01/2013
1	CreatinineIBA 06/2006
1	efavirenz (Sustiva)FDA Link 04/2006
1	N-acetyltalosaminuronic acid (NAT)IBA 05/2004

12	Therapeutics 01/2018 - 10/2003
2	Highly Active Antiretroviral Therapy (HAART) 01/2010 - 05/2004
1	Catheter Ablation 09/2021
1	Aftercare (After-Treatment) 01/2020
1	Drug Therapy (Chemotherapy) 12/2018